Preclinical efficacy of hK2 targeted [(177)Lu]hu11B6 for prostate cancer theranostics

Androgen ablating drugs increase life expectancy in men with metastatic prostate cancer, but resistance inevitably develops. In a majority of these recurrent tumors, the androgen axis is reactivated in the form of increased androgen receptor (AR) expression. Targeting proteins that are expressed as...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Theranostics
Main Authors: Timmermand, Oskar Vilhelmsson, Elgqvist, Jörgen, Beattie, Kai A., Örbom, Anders, Larsson, Erik, Eriksson, Sophie E., Thorek, Daniel L.J., Beattie, Bradley J., Tran, Thuy A., Ulmert, David, Strand, Sven-Erik
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2019
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6531309/
https://ncbi.nlm.nih.gov/pubmed/31149033
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.31179
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados